Pharma and biotech concerned about the stability of large CROs, survey finds
The survey by CRO Worldwide Clinical Trials shows that pharma and biotechs favour midsize CROs due to the personalised service.
The survey by CRO Worldwide Clinical Trials shows that pharma and biotechs favour midsize CROs due to the personalised service.
What's Your Reaction?
